Active Ingredient: BRIMONIDINE TARTRATE; BRINZOLAMIDE
Proprietary Name: SIMBRINZA
Dosage Form; Route of Administration: SUSPENSION/DROPS; OPHTHALMIC
Strength: 0.2%;1%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N204251
Product Number: 001
Approval Date: Apr 19, 2013
Applicant Holder Full Name: ALCON LABORATORIES INC
Marketing Status:
Prescription
Patent and Exclusivity Information
